SAFETY AND EFFICACY OF DEXMEDETOMIDINE-KETAMINE COMBINATION VS DEXMEDETOMIDINE ALONE FOR PEDIATRIC DENTAL SEDATION: A SYSTEMATIC REVIEW AND META-ANALYSIS
Journal of Evidence-Based Dental Practice · 2025
DOI: 10.1016/j.jebdp.2025.102158 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Evidence-Based Dental Practice, 2025. Verfasst von Ahmad Abdul Kader Abuokal und 4 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Dentistry, Misr University for Science & Technology, Cairo, Egypt. Electronic address: ahmedokal@gmail.com. Hauptthemen laut MEDLINE: Dexmedetomidine, Ketamine, Hypnotics and Sedatives, Procedural Sedation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 29 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Dexmedetomidine (D) and ketamine are widely used for pediatric dental sedation, each presenting unique benefits and potential adverse effects. Combining these agents, referred to as DK, was suggested to provide a balanced approach to pediatric sedation. This is the first systematic review and meta-analysis to evaluate the efficacy and safety of DK versus dexmedetomidine alone in pediatric dental procedures. METHODS: A systematic search was conducted in PubMed, Scopus, Web of Science, Embase, and CENTRAL, identifying randomized controlled trials (RCTs) comparing DK to D alone. Eligible studies were screened, and data were extracted following PRISMA guidelines. Meta-analyses were conducted using random effects models through RevMan software. RESULTS: Five studies involving 308 pediatric patients were included. Meta-analysis showed no significant difference in onset of sedation time (MD = -0.02 minutes; 95% CI = [-3.27, 3.23]; P = .99; I² = 29%), duration of sedation (MD = -7.39 minutes; 95% CI = [-21.69, 6.91]; P = .31; I² = 95%), or recovery time (MD = 4.71 minutes; 95% CI = [-12.80, 22.23]; P = .60; I² = 92%). Analysis of Anxiety and pain scores favored DK (SMD = -0.67; 95% CI = [-1.20, -0.14]; P = .01; I² = 35%), (MD = -1.11; 95% CI = [-2.04, -0.19]; P = .02; I² = 20%), respectively. Adverse events, including bradycardia, hypotension, and agitation, vomiting, nausea showed no significant differences between groups. CONCLUSION: The combination of DK does not offer significant advantages over dexmedetomidine alone for pediatric dental sedation. However, DK showed a moderate reduction in anxiety and pain with a favorable safety profile, suggesting it is a viable option in clinical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Dentistry, Misr University for Science & Technology, Cairo, Egypt. Electronic address: ahmedokal@gmail.com.
- Faculty of Dentistry, Damascus University, Damascus, Syria.
- Faculty of Dentistry, Tishreen University, Tishreen, Syria.
- Faculty of Dentistry, Horus University, Cairo, Egypt.
- Faculty of Dentistry, Alexandria University, Alexandria, Egypt.
Zitieren
APA
Abuokal, A. A. K., Rihan, M., Hjazi, A. A., Elemam, A. I. M. I., & Mohamed, M. M. R. A. E. (2025). SAFETY AND EFFICACY OF DEXMEDETOMIDINE-KETAMINE COMBINATION VS DEXMEDETOMIDINE ALONE FOR PEDIATRIC DENTAL SEDATION: A SYSTEMATIC REVIEW AND META-ANALYSIS. Journal of Evidence-Based Dental Practice. https://doi.org/10.1016/j.jebdp.2025.102158
Vancouver
Abuokal AAK, Rihan M, Hjazi AA, Elemam AIMI, Mohamed MMRAE. SAFETY AND EFFICACY OF DEXMEDETOMIDINE-KETAMINE COMBINATION VS DEXMEDETOMIDINE ALONE FOR PEDIATRIC DENTAL SEDATION: A SYSTEMATIC REVIEW AND META-ANALYSIS. Journal of Evidence-Based Dental Practice. 2025. doi:10.1016/j.jebdp.2025.102158
BibTeX
@article{Abuokal2025,
author = {Abuokal, Ahmad Abdul Kader and Rihan, Mouhammed and Hjazi, Abdulkarim Albacha and Elemam, Abdalla Ibrahem Mohammed Ibrahem and Mohamed, Mamdouh Mohamed Ragaey Ahmed Ezzat},
title = {SAFETY AND EFFICACY OF DEXMEDETOMIDINE-KETAMINE COMBINATION VS DEXMEDETOMIDINE ALONE FOR PEDIATRIC DENTAL SEDATION: A SYSTEMATIC REVIEW AND META-ANALYSIS},
journal = {Journal of Evidence-Based Dental Practice},
year = {2025},
doi = {10.1016/j.jebdp.2025.102158}
}
EUVIMED